Controversies Challenges Consensus
}

CX 2020 LIVE to flag latest guidelines and stent durability in superficial and deep venous programmes

2020-05-20T12:57:01+01:00

Manj Gohel (Cambridge, UK), who is also a member of the CX Venous Executive Board, welcomes you to CX 2020 LIVE, which will include some of the major highlights from the deep and superficial venous programmes.

A number of recently released “important guidelines” in the superficial venous space will be presented […]

CX 2020 LIVE to flag latest guidelines and stent durability in superficial and deep venous programmes2020-05-20T12:57:01+01:00

CX 2020 LIVE: Durability of EVAR, sac diameter and NICE guidelines take the spotlight in first aortic session

2020-05-18T18:09:13+01:00

World-leading vascular surgeon, Stéphan Haulon (Paris, France), who is also a member of the CX Aortic Executive Board, extols the “high-quality” digital educational programme of CX 2020 LIVE and highlights the “very exciting” thoracic aortic and abdominal aortic consensus sessions that will be chaired by a host of other experts […]

CX 2020 LIVE: Durability of EVAR, sac diameter and NICE guidelines take the spotlight in first aortic session2020-05-18T18:09:13+01:00

COVID-19: No evidence of increased aortic emergencies in Lombardy

2020-05-19T10:33:36+01:00

Roberto Chiesa (Milan, Italy), who was at the frontline of the COVID-19 pandemic in the Lombardy region of Italy, shares his team’s experience in tackling vascular and aortic emergencies during this time.

Chiesa outlines the response in the region to the pandemic, including the creation of new intensive care units (ICUs) […]

COVID-19: No evidence of increased aortic emergencies in Lombardy2020-05-19T10:33:36+01:00

Paclitaxel controversy to headline inaugural CX 2020 LIVE session

2020-07-09T23:32:08+01:00


Join a wealth of experts and faculty from around the world for the very first session of CX 2020 LIVE—the inaugural virtual Charing Cross (CX) Symposium—titled ‘Paclitaxel-coated Device Consensus Update’.

Renowned interventional radiologist Andrew Holden (Auckland, New Zealand), who is a member of the CX Peripheral Arterial Executive Board, welcomes the […]

Paclitaxel controversy to headline inaugural CX 2020 LIVE session2020-07-09T23:32:08+01:00

CX 2020 LIVE: Charing Cross Symposium unveils live, interactive digital event

2020-05-13T17:13:26+01:00

The Charing Cross (CX) Symposium, with its world-class faculty and unique focus on live audience participation, has announced the launch of a not-to-be missed and timely vascular and endovascular education virtual event: CX 2020 LIVE. Mark your calendars for this live digital experience, designed to deliver high-quality vascular education and featuring […]

CX 2020 LIVE: Charing Cross Symposium unveils live, interactive digital event2020-05-13T17:13:26+01:00

Long-term partnership helps drive CX Symposium forward

2020-03-06T09:50:48+00:00

Roger Greenhalgh (London, UK) and W L Gore’s Michael Koenke (Flagstaff, USA), take a look back at the history of the Charing Cross Symposium (CX), which began in 1978.

Koenke says that CX is a “special meeting for us”, adding that it is an “opportunity for us to connect with our […]

Long-term partnership helps drive CX Symposium forward2020-03-06T09:50:48+00:00

Type II endoleak with secondary sac expansion remains elusive

2020-01-08T13:00:32+00:00

Leading experts including Robert Morgan (London, UK), Richard McWilliams (Liverpool, UK), Stéphan Haulon (Paris, France), Tilo Kölbel (Hamburg, Germany) and Peter Schneider (Honolulu, USA) discuss the various approaches to correcting endoleak during CX 2018 (Charing Cross Symposium; 24–27 April 2018; London, UK).

Type II endoleak with secondary sac expansion remains elusive2020-01-08T13:00:32+00:00
Go to Top